Charles River Laboratories International, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-99.00
93.00
581.00
622.00
480.00
447.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
14.00
-30.00
-102.00
-152.00
42.00
-26.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
737.00
734.00
683.00
619.00
760.00
546.00
Cash Flow from Investing Activities
-209.00
-245.00
-563.00
-607.00
-1,437.00
-601.00
Cash Flow from Financing Activities
-536.00
-550.00
-85.00
-42.00
672.00
47.00
Net Cash Inflow / Outflow
10.00
-78.00
43.00
-5.00
13.00
-6.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
18.00
-17.00
8.00
25.00
17.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Charles River Laboratories International, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-99.503
1219
-1,318.00
-108.16%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
14.081
-128
142.00
111.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
737.646
1009
-272.00
-26.89%
Cash Flow from Investing Activities
-209.321
-218
9.00
3.98%
Cash Flow from Financing Activities
-536.726
-460
-76.00
-16.68%
Net Cash Inflow / Outflow
10.427
331
-321.00
-96.85%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
18.828
0
18.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 0.42% vs 7.41% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
737.65
734.58
0.42%






